Change Agents Corporation. (ALBT) Form 8-K — Oct 16, 2026

$ALBTForm 8-KItems 5.02Filed Oct 16, 2026, 9:00 AM ET0001213900-26-110039Original filing

Change Agents Corporation appointed Eric Weisblum as an independent director on its board, effective October 12, 2026, per an 8-K filed October 16, 2026. He will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees. Weisblum is CEO and founder of Silo Pharma Inc., and previously held Series 7, 63, and 55 registrations at Domestic Securities and structured financing roles at M.H. Meyerson & Co.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.